Devonian Health Group (TSXV:GSD) Cash-to-Debt : 5.48 (As of Oct. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Devonian Health Group Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Devonian Health Group's cash to debt ratio for the quarter that ended in Oct. 2024 was 5.48.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Devonian Health Group could pay off its debt using the cash in hand for the quarter that ended in Oct. 2024.

The historical rank and industry rank for Devonian Health Group's Cash-to-Debt or its related term are showing as below:

TSXV:GSD' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.06 Med: 1.38 Max: No Debt
Current: 5.48

During the past 11 years, Devonian Health Group's highest Cash to Debt Ratio was No Debt. The lowest was 0.06. And the median was 1.38.

TSXV:GSD's Cash-to-Debt is ranked worse than
54.41% of 1485 companies
in the Biotechnology industry
Industry Median: 7.49 vs TSXV:GSD: 5.48

Devonian Health Group Cash-to-Debt Historical Data

The historical data trend for Devonian Health Group's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Devonian Health Group Cash-to-Debt Chart

Devonian Health Group Annual Data

Trend

Jun15

Jun16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Jul24

Cash-to-Debt

Get a 7-Day Free Trial

0.20

0.07

1.82

1.38

4.39

Devonian Health Group Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Cash-to-Debt	Get a 7-Day Free Trial															1.35	6.69	1.61	4.39	5.48

Competitive Comparison of Devonian Health Group's Cash-to-Debt

For the Biotechnology subindustry, Devonian Health Group's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Devonian Health Group's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Devonian Health Group's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Devonian Health Group's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

Devonian Health Group Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Devonian Health Group's Cash to Debt Ratio for the fiscal year that ended in Jul. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	9.863	/	(2.12	+	0.126)
	=	4.39

Devonian Health Group's Cash to Debt Ratio for the quarter that ended in Oct. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	12.455	/	(2.157	+	0.114)
	=	5.48

Devonian Health Group (TSXV:GSD) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Devonian Health Group Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Devonian Health Group's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Devonian Health Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Devonian Health Group Inc (TSXV:GSD) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

DVHGF:USA

Address

360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1

Website

https://www.groupedevonian.com

Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.

Devonian Health Group Headlines

No Headlines